Arce-Gallego S, Cresta Morgado P, Delgado-Serrano L, Simonetti S, Gonzalez M, Romero-Lozano P, Marmolejo D, Morales-Barrera R, Arnau GM, Semidey ME, Aguilar D, Cordoba-Terreros S, Mast R, de Albert M, Planas J, Cuadras M, Maldonado X, Suarez C, Casanova-Salas I, Figols M, Cros S, Mas A, Nonell L, Dienstmann R, Nuciforo P, Vivancos A, Llop-Guevara A, Carles J, Serra V, Mateo J
Homologous recombination repair status in metastatic prostate cancer by next-generation sequencing and functional immunofluorescence
Cell Rep Med. 2025 Feb 18;6(2):101937.
DOI: 10.1016/j.xcrm.2025.101937
IF: 10.6
RESEARCH GROUPS
Musculoskeletal Tissue Engineering
8
Number of publications
75.00
%
% Q1
50.00
%
% D1
75.00
%
% Leadership
16.67
%
% Female Leadership
1.58
CROWN (2021-2025)
19.57
%
HCP10% (2021-2025)
87.50
%
% Open access
25.00
%
% International Collaboration
0
Highly cited papers / HCP 1% (2021-2025)
1
Publications in high-IF journals with high Altmetric scores
4
Number of Ongoing Projectes (total)
0
International ongoing projects
1
Number of New projects (total)
0
International new projects
0
Number of Active clinical Trials
0
Number of New Clinical Trials
3
Number of Theses
The mission of this group is to develop cell and tissue-based therapies in the field of regenerative medicine. They are focused in design, conduct and transform preclinical efforts into clinical trials mainly in bone regeneration that could be used in different indications. The team holds a high degree of knowledge and translational experience thanks to several years working in the field and have also established successful collaboration with partners from different fields.
CORE/MISSIONS
- Innovative & Advanced Therapies
- Transplant & Immunomodulation
PROGRAMS
TEAM
Group Leader
Roberto Vélez Villa
Principal Investigator (PI)
Joaquim Vives Nayana, Daniel Alejandro Pacha Vicente, Margalida Hernandez Vicens, Anna Server Salvà, Nayana Joshi Jubert
Researchers
Raquel Cabrera Perez, Joan Albert Prat Matifoll, Màrius Aguirre Canyadell
SELECTED PUBLICATIONS
Güell-Alonso R, Cabrera-Pérez R, Vives J
Immunocompatibility in transplantation: adapting to a changing therapeutic landscape
Front Immunol. 2025 Sep 9;16:1648534.
DOI: 10.3389/fimmu.2025.1648534
IF: 5.9
Cabrera-Pérez R, Carreras-Sánchez I, Roig-Molina Á, López-Fernández A, Portas-Torres I, Batlle-Morera L, Vélez R, Vives J
Preclinical Assessment in Juvenile Sheep of an Allogeneic Bone Tissue Engineering Product with Wharton's Jelly Mesenchymal Stromal Cells
Cells. 2025 Jun 7;14(12):862
DOI: 10.3390/cells14120862
IF: 5.2
Zamora T, Botello E, Jenkins T, Jeys C, Laitinen M, Puri A, Jeys L; BOOM consensus meeting participants
Global and regional disparities in access to specialist sarcoma services
Bone Jt Open. 2025 Apr 11;6(4):425-431
DOI: 10.1302/2633-1462.64.bjo-2024-0208.r1
IF: 5.1
Joshi Jubert N, Vinaixa MR, Torres IP, Moreno Martínez D, Casaccia M, Garcia MA, Bueno JP, Feliu EC, Monyart JM
AMIC achieves sustained clinical improvement in isolated patellar cartilage defects over 5 years, correlating with MRI
Knee Surg Sports Traumatol Arthrosc. 2025 Jun;33(6):2104-2113
DOI: 10.1002/ksa.12518
IF: 5.0
SELECTED PROJECTS
Traslación de un producto alogénico de ingeniería tisular para el tratamiento de lesiones focales del cartílago articular
Principal Investigator: Joaquim Vives Armengol
Agency: Instituto de Salud Carlos III
Funding: 105,270 €
Period: 2023-2025
Pot un tercer clau intramedul·lar flexible ser una opció de tractament en fractures diafisàries de fèmur inestables? Anàlisi biomecànica
Principal Investigator: Daniel Alejandro Pacha Vicente
Agency: Acadèmia Ciències Mèdiques Catalunya i Balears
Funding: 8,000 €
Period: 2023-2025
SHARESPACE: Embodied Social Experiences in Hybrid Shared Spaces
Principal Investigator: Anna Server Salvà
Agency: EUROPEAN COMMISSION
Funding: 144,620 €
Period: 2023-2025
PATENTS
DISSEMINATION ACTIVITIES
